However, MMP-9 levels, typically over-expressed in CF people, were reduced 1.8-fold post-LUM/IVA initiation in clinical responders, characterized by a combined increase in BMI (≥0.3) and FEV1 (≥3%). Here, MMP9 is linked to cystic fibrosis.